David Veitch
Vermogen: 2 M $ op 30-06-2026
Vermogen: 2 M $ op 30-06-2026
David Veitch is Chief Executive Officer at Basilea Pharmaceutica AG since 2018, with employment at the firm starting in 2014.
Formerly, Mr. Veitch was President-European Operations at Savient Pharmaceuticals, Inc. from 2012 to 2013.
Prior to that, Mr. Veitch was SVP-European Marketing & Brand Commercialization at Bristol-Myers Squibb Pharmaceuticals Ltd. from 2007 to 2011.
Education includes an undergraduate degree from the University of Bristol.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-12-2025 | 25.660 ( 0,19% ) | 2 M $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| BASILEA PHARMACEUTICA AG | Algemeen Directeur | 19-04-2018 |
| Bedrijven | Functie | Einde |
|---|---|---|
| SAVIENT PHARMACEUTICALS INC | Corporate Officer/Principal | 01-01-2013 |
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01-01-2011 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Savient Pharmaceuticals, Inc.
Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products | Health Technology |
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Basilea Pharmaceutica AG
Basilea Pharmaceutica AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
University of Bristol
University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau